Table 1 Relationship of different variables in study population with IL17 expression
IL17 expression | Total (n = 137) | P value | ||||
|---|---|---|---|---|---|---|
No expression | Mild | Moderate | Strong | |||
Age group | ||||||
Not more than 20 | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.7%) | 0.065 |
21 to 40 years | 13 (43.3%) | 5 (16.7%) | 7 (23.3%) | 5 (16.7%) | 30 (21.9%) | |
41 to 60 years | 38 (44.7%) | 13 (15.3%) | 9 (10.6%) | 25 (29.4%) | 85 (62.0%) | |
Above 60 years | 5 (29.4%) | 2 (11.8%) | 8 (47.1%) | 2 (11.8%) | 17 (12.4%) | |
Tumor type | ||||||
Benign | 23 (57.5%) | 0 (0.0%) | 10 (25.0%) | 7 (17.5%) | 40 (29.2%) | 0.002 |
Malignant | 34 (34.1%) | 22 (22.7%) | 15 (15.5%) | 26 (26.8%) | 97 (70.8%) | |
Diagnosis of breast lesion | ||||||
IDC | 30 (34.5%) | 19 (21.8%) | 13 (14.9%) | 25 (28.7%) | 87 (63.5%) | 0.035 |
DE | 7 (63.6%) | 0 (0.0%) | 4 (36.4%) | 0 (0.0%) | 11 (8.0%) | |
FA | 12 (57.1%) | 0 (0.0%) | 6 (28.6%) | 3 (14.3%) | 21 (15.3%) | |
FC | 2 (50.0%) | 0 (0.0%) | 0 (0.0%) | 2 (50.0%) | 4 (2.9%) | |
IDCS | 2 (66.7%) | 1 (33.3%) | 0 (0.0%) | 0 (0.0%) | 3 (2.2%) | |
ILC | 2 (28.6%) | 2 (28.6%) | 2 (28.6%) | 1 (14.3%) | 7 (5.1%) | |
Lipoma | 2 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (1.5%) | |
PTS | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (100%) | 2 (1.5%) | |
ER | ||||||
Mild | 10 (37.0%) | 7 (25.9%) | 3 (11.1%) | 7 (25.9%) | 27 (19.7%) | 0.678 |
Moderate | 3 (21.4%) | 4 (28.6%) | 4 (28.6%) | 3 (21.4%) | 14 (10.2%) | |
Strong | 5 (29.4%) | 5 (29.4%) | 1 (5.9%) | 6 (35.3%) | 17 (12.4%) | |
No expression | 16 (41.0%) | 6 (15.4%) | 7 (17.9%) | 10 (25.6%) | 39 (28.5%) | |
PR | ||||||
Mild | 9 (37.5%) | 6 (25.0%) | 3 (12.5%) | 6 (25.0%) | 24 (17.5%) | 0.623 |
Moderate | 3 (30.0%) | 3 (30.0%) | 1 (10.0%) | 3 (30.0%) | 10 (7.3%) | |
Strong | 1 (8.3%) | 3 (25.0%) | 2 (16.7%) | 6 (50.0%) | 12 (8.8%) | |
No expression | 21 (41.2%) | 10 (19.6%) | 9 (17.6%) | 11 (21.6%) | 51 (37.2%) | |
HER2 | ||||||
Mild | 7 (35.0%) | 7 (35.0%) | 0 (0.0%) | 6 (30.0%) | 20 (14.6%) | 0.361 |
Moderate | 7 (46.7%) | 2 (13.3%) | 3 (20.0%) | 3 (20.0%) | 15 (10.9%) | |
Strong | 8 (33.3%) | 3 (12.5%) | 4 (16.7%) | 9 (37.5%) | 24 (17.5%) | |
No expression | 12 (31.6%) | 10 (26.3%) | 8 (21.1%) | 8 (21.1%) | 38 (27.7%) | |